Treatment and control of porcine proliferative enteropathy using different tiamulin delivery methods

Journal of Swine Health and Production

Volumn 9, Issue 3, 2001, Pages 109-115

  Walter, Don ^a   Knittel, Jeff ^a   Schwartz, Kent ^b   Kroll, Jeremy ^a   Roof, Mike ^a  

^a BOEHRINGER INGELHEIM VETMEDICA INC   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Lawsonia intracellularis; Proliferative enteropathy; Swine; Tiamulin

Indexed keywords

EID: 1442271283     PISSN: 1537209X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. McOrist S, Gebhart CJ, Boid R, Barns SM. Characterization of Lawsonia intracellularis gen. Nov., sp. Nov., the obligately intracellular bacterium of porcine proliferative enteropathy. Int J Syst Bact. 1995;45:820-825.
2. McOrist S, Gebhart C. Porcine proliferative enteropathies. In: BE Straw, et al, eds. Diseases of Swine. 8th ed. Ames, IA: Iowa State University Press; 1999:521-534.
3. Jones GF, Ward GE, Murtaugh MP, Lin G, Gebhart CJ. Enhanced detection of intracellular organism of swine proliferative enteritis Ileal Symbiont intracellularis in feces by polymerase chain reaction. J Clin Micro. 1993;31:2611-2615.
4. Knittel JP, Jordan DM, Schwartz KJ, Janke BH, Roof MB, McOrist S, Harris DL. Evaluation of ante-mortem PCR and serological methods for the detection of Lawsonia intracellularis exposed pigs. Am J Vet Res. 1998;59:722-726.
5. McOrist S, Jasni S, Mackie RA, N. MacIntyre, Neef N, Lawson GHK. Reproduction of porcine proliferative enteritis with pure cultures of Ileal Symbiont intracellularis. Inf Imm. 1993;61:4286-4292
6. McOrist S, Gebhart CJ. In vitro testing of antimicrobial agents for proliferative enteropathy (ileitis). Swine Health Prod. 1995:146-149.
7. McOrist S, Mackie RA, Lawson GHK. Antimicrobial susceptibility of Ileal Symbiont intracellularis isolated from pigs with proliferative enteropathy. J Clin Micro. 1995;22:1314-1317.
8. Schwartz K, Knittel J, Walter D, Roof M, Anderson M. Effect of oral tiamulin on the development of porcine proliferative enteropathy in a pure culture challenge model. Swine Health Prod. 1999;7:5-11.
9. McOrist S, Smith SH, Shearn MFH, Carr MM, Miller DJS. Treatment and prevention of porcine proliferative enteropathy with oral tiamulin. Vet Rec. 1996;139:615-618.
10. Reed LJ, Meunch H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1936;27:493-497.
11. Walter D, Holck JT, Sornsen S, Hagen C, Harris I. The effect of a metaphylactic pulse dosing infeed antimicrobial strategy on finishing pig health and performance. Swine Health Prod. 2000; 8:65-71.
12. TM) activity in certain swine tissues following oral and intramuscular administration. Proc AASP Ann Meet. 1994;115-117.
13. Nielsen B, Szancer J. Uptake and intracellular activity of tiamulin in human polymorphonuclear leukocytes compared with norfloxacin. Proc Int Pig Vet Soc. 1998;(3)241.
14. Collins A, van Dijk M, McOrist S, Love R. Strategic medication and development of immunity to Lawsonia intracellularis. Proc Int Pig Vet Soc. 2000;30.
15. Bane D, Norby B, Gardner I, Roof M, Knittel J, Bush E, Gebhart C. The epidemiology of porcine proliferative enteropathy. Proc Int Pig Vet Soc. 1998; (3)107.